About this trial
The goal of this proposed research is to collect pilot data to test the hypothesis that treatment with a novel form of closed-loop digital meditation (MediTrain) will lead to a greater magnitude of gains in cognitive abilities in patients with mild cognitive impairment (MCI), compared to OA without cognitive impairment, and will lead to improvements in quantitative measures of sleep.
Eligibility criteria
Qualifiers
comfortably ambulatory healthy physical condition
normal or corrected to normal visual
auditory acuity
fluency in spoken English
Disqualifiers
None
Trial design
Treatments tested in this trial
- MediTrain
- wrist worn multi-sensor watches
- Sleep monitor
Treatment groups
90 Participants
are divided into 1 treatment groupSponsors and collaborators
University of California, San Francisco
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov